Sava Infond’s Gilead Sciences GILD Stock Holding History

Sava Infond’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Hold	2,740	–	–	0.02%	160
2026 Q1	$382K	Buy	+2,740	New	+$384K	0.05%	156

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sava Infond's GILD Position: Q2 2026 in Review

Sava Infond held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,740 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #160.

Sava Infond first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $382K in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Sava Infond held 2,740 shares of Gilead Sciences worth $346K as of Q2 2026.
Sava Infond left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.02% of Sava Infond's portfolio in Q2 2026, its #160 holding.
Sava Infond first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
Sava Infond's Gilead Sciences position peaked at $382K in Q1 2026.
2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.